Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
96M
-
Number of holders
-
127
-
Total 13F shares, excl. options
-
48.1M
-
Shares change
-
+6.3M
-
Total reported value, excl. options
-
$1.09B
-
Value change
-
+$167M
-
Put/Call ratio
-
1.71
-
Number of buys
-
75
-
Number of sells
-
-41
-
Price
-
$22.70
Significant Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) as of Q4 2023
147 filings reported holding CABA - Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share as of Q4 2023.
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) has 127 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.1M shares
of 96M outstanding shares and own 50.11% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.41M shares), FRED ALGER MANAGEMENT, LLC (3.33M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3.27M shares), STATE STREET CORP (2.59M shares), VR Adviser, LLC (2.56M shares), VANGUARD GROUP INC (2.13M shares), Lynx1 Capital Management LP (2.11M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.01M shares), PERCEPTIVE ADVISORS LLC (2M shares), and Bain Capital Life Sciences Investors, LLC (2M shares).
This table shows the top 127 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.